SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001558370-20-001232
Filing Date
2020-02-24
Accepted
2020-02-24 16:11:11
Documents
14
Period of Report
2020-02-24
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K xncr-20191220x8kd26b5ac.htm   iXBRL 8-K 36093
2 EX-99.1 ex-99d1.htm EX-99.1 312261
3 GRAPHIC ex-99d1g001.jpg GRAPHIC 3491
  Complete submission text file 0001558370-20-001232.txt   486721

Data Files

Seq Description Document Type Size
4 EX-101.SCH xncr-20191220.xsd EX-101.SCH 3028
5 EX-101.LAB xncr-20191220_lab.xml EX-101.LAB 15410
6 EX-101.PRE xncr-20191220_pre.xml EX-101.PRE 9959
11 EXTRACTED XBRL INSTANCE DOCUMENT xncr-20191220x8kd26b5ac_htm.xml XML 4666
Mailing Address 111 WEST LEMON AVE MONROVIA CA 91016
Business Address 111 WEST LEMON AVE MONROVIA CA 91016 626-305-5900
Xencor Inc (Filer) CIK: 0001326732 (see all company filings)

IRS No.: 201622502 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36182 | Film No.: 20644404
SIC: 2834 Pharmaceutical Preparations